Role of PU.1 Expression as an Inflammatory Marker in Experimental Autoimmune Uveoretinitis

REFERENCES

• Lloberas J, Soler C, Celada A. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol. 1999;20:184–189.
   Web of Science ®Google Scholar
• Back J, Allman D, Chan S, Kastner P. Visualizing PU.1 activity during hematopoiesis. Exp Hematol. 2005; 33:395–402.
   PubMed Web of Science ®Google Scholar
• McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996;15:5647–5658.
   PubMed Web of Science ®Google Scholar
• Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994;265:1573–1577.
   PubMed Web of Science ®Google Scholar
• Scott EW, Fisher RC, Olson MC, et al. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity. 1997;6:437–447.
   PubMed Web of Science ®Google Scholar
• Dahl R, Walsh JC, Lancki D, et al. Regulation of macrophage and neutrophil cell fates by the PU.1: C/EBPalpharatio and granulocyte colony-stimulating factor. Nat Immunol. 2003;4:1029–1036.
   PubMed Web of Science ®Google Scholar
• Laslo P, Spooner CJ, Warmflash A, et al. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell. 2006;126:755–766.
   PubMed Web of Science ®Google Scholar
• DeKoter RP, Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 2000;288:1439–1441.
   PubMed Web of Science ®Google Scholar
• Kanada S, Nishiyama C, Nakano N, et al. Critical role of transcription factor PU.1 in the expression of CD80 and CD86 on dendritic cells. Blood. 2011;117:2211–2222.
   PubMed Web of Science ®Google Scholar
• Kitamura N, Yokoyama H, Yashiro T, et al. Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells. J. Allergy Clin Immunol. 2012;129:814–824.e816.
   PubMed Web of Science ®Google Scholar
• Karpurapu M, Wang X, Deng J, et al. Functional PU.1 in macrophages has a pivotal role in NF-kappaB activation and neutrophilic lung inflammation during endotoxemia. Blood. 2011;118:5255–5266.
   PubMed Web of Science ®Google Scholar
• Ponomarev ED, Veremeyko T, Barteneva N, et al. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med. 2011;17:64–70.
   PubMed Web of Science ®Google Scholar
• Xu XW, Ding BW, Zhu CR, et al. PU.1-silenced dendritic cells prolong allograft survival in rats receiving intestinal transplantation. World J Gastroenterol. 2013;19:7766–7771.
   PubMed Web of Science ®Google Scholar
• Al-Kharashi AS, Aldibhi H, Al-Fraykh H, et al. Prognostic factors in Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2007;27:201–210.
   PubMedGoogle Scholar
• Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88:1159–1162.
   PubMed Web of Science ®Google Scholar
• Lobo A, Barton K, Minassian D, et al. Visual loss in sarcoid-related uveitis. Clin Exp Ophthalmol. 2003;31:310–316.
   PubMed Web of Science ®Google Scholar
• Yang P, Fang W, Meng Q, et al. Clinical features of chinese patients with Behcet’s disease. Ophthalmology. 2008;115:312–318.e314.
   PubMed Web of Science ®Google Scholar
• Luger D, Caspi RR. New perspectives on effector mechanisms in uveitis. Semin. Immunopathol. 2008;30:135–143.
   PubMed Web of Science ®Google Scholar
• Rizzo LV, Silver P, Wiggert B, et al. Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice. J Immunol. 1996;156:1654–1660.
   PubMed Web of Science ®Google Scholar
• Sanui H, Redmond TM, Kotake S, et al. Identification of an immunodominant and highly immunopathogenic determinant in the retinal interphotoreceptor retinoid-binding protein (IRBP). J Exp Med. 1989;169:1947–1960.
   Google Scholar
• Amadi-Obi A, Yu CR, Liu X, et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med. 2007;13:711–718.
   PubMed Web of Science ®Google Scholar
• Luger D, Silver PB, Tang J, et al. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med. 2008;205:799–810.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Sonoda KH, Miyazaki Y, et al. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol. 2008;20:209–214.
   PubMed Web of Science ®Google Scholar
• Jiang HR, Lumsden L, Forrester JV. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci. 1999;40:3177–3185.
   PubMed Web of Science ®Google Scholar
• Dick AD, Kreutzer B, Laliotou B, Forrester JV. Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin A and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration. Ocul Immunol Inflamm. 1997;5:129–140.
   PubMed Web of Science ®Google Scholar
• Forrester JV, McMenamin PG, Holthouse I, et al. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye: implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci. 1994;35:64–77.
   PubMed Web of Science ®Google Scholar
• Usui Y, Takeuchi M, Hattori T, et al. Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice. Arch Ophthalmol. 2009;127:514–519.
   PubMedGoogle Scholar
• Chan CC, Caspi RR, Ni M, et al. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun. 1990;3:247–255.
   PubMed Web of Science ®Google Scholar
• Thurau SR, Chan CC, et al. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin Exp Immunol. 1997;109:370–376.
   PubMed Web of Science ®Google Scholar
• Sugita S, Streilein JW. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J Exp Med. 2003;198:161–171.
   PubMed Web of Science ®Google Scholar
• Connor KM, Krah NM, Dennison RJ, et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc. 2009;4:1565–1573.
   PubMed Web of Science ®Google Scholar
• Lehmann U, Heuss ND, McPherson SW, et al. Dendritic cells are early responders to retinal injury. Neurobiol Dis. 2010;40:177–184.
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Somoza C, Shigematsu H, et al. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood. 2005;106:1590–1600.
   PubMed Web of Science ®Google Scholar
• Carotta S, Dakic A, D’Amico A, et al. The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity. 2010;32:628–641.
   PubMed Web of Science ®Google Scholar
• Dakic A, Metcalf D, Di Rago L, et al. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med. 2005;201:1487–1502.
   PubMed Web of Science ®Google Scholar
• Chang HC, Sehra S, Goswami R, et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol. 2010;11:527–534.
   PubMed Web of Science ®Google Scholar
• Kaplan HJ, Streilein JW. Do immunologically privileged sites require a functioning spleen? Nature. 1974;251:553–554.
   Google Scholar
• Butler TL, McMenamin PG. Resident and infiltrating immune cells in the uveal tract in the early and late stages of experimental autoimmune uveoretinitis. Invest Ophthalmol. 1996;37:2195–2210.
   Google Scholar
• Forrester JV, McMenamin PG. Immunopathogenic mechanisms in intraocular inflammation. Chem Immunol. 1999;73:159–185.
   PubMedGoogle Scholar
• Becker C, Wirtz S, Ma X, et al. Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2). J Immunol. 2001;167:2608–2618.
   PubMed Web of Science ®Google Scholar
• Fukai T, Nishiyama C, Kanada S et al. Involvement of PU.1 in the transcriptional regulation of TNF-alpha. Biochem Biophys Res Commun. 2009;388:102–106.
   PubMed Web of Science ®Google Scholar
• Grove M, Plumb M, C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene. Mol Cell Biol. 1993;13:5276–5289.
   PubMed Web of Science ®Google Scholar
• Liu J, Ma X. Interferon regulatory factor 8 regulates RANTES gene transcription in cooperation with interferon regulatory factor-1, NF-kappaB, and PU.1. J Biol Chem. 006;281:19188–19195.
   PubMed Web of Science ®Google Scholar
• Dick AD, Forrester JV, Liversidge J, Cope AP. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog Retin Eye Res. 2004;23:617–637.
   PubMed Web of Science ®Google Scholar
• Keino H, Watanabe T, Sato Y, et al. Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis. Arthritis Res Ther. 2008;10:R122.
   PubMed Web of Science ®Google Scholar
• Manczak M, Jiang S, Orzechowska B, Adamus G. Crucial role of CCL3/MIP-1alpha in the recurrence of autoimmune anterior uveitis induced with myelin basic protein in Lewis rats. J Autoimmun. 2002;18:259–270.
   PubMed Web of Science ®Google Scholar
• Park SY, Lee SW, Baek SH, et al. Suppression of PU.1-linked TLR4 expression by cilostazol with decrease of cytokine production in macrophages from patients with rheumatoid arthritis. Br J Pharmacol. 2013;168:1401–1411.
   PubMed Web of Science ®Google Scholar